Keyphrases
Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Low Incidence
100%
Conditioning Regimen
100%
Chronic Myeloid Leukemia
100%
Total Body Irradiation
100%
Acute Complications
100%
Graft-versus-host Disease (GvHD)
40%
Preparative Regimen
40%
Non-relapse Mortality
40%
Allogeneic Peripheral Blood Stem Cell Transplantation
40%
Confidence Interval
20%
Remission
20%
Adult Patients
20%
High Dose
20%
Immunosuppression
20%
Pretransplant
20%
Kaplan-Meier Estimator
20%
In(III)
20%
Cyclosporine
20%
Curative Treatment
20%
Treatment-related Mortality
20%
Graft Failure
20%
Phase II Trial
20%
Hematologic
20%
Allogeneic Transplantation
20%
Cyclophosphamide
20%
Severe Acute
20%
Multiple Exposures
20%
Organ Toxicity
20%
Leukemia Therapy
20%
Donor Engraftment
20%
HLA-matched Donor
20%
Older Cohort
20%
Low-dose Irradiation
20%
Oral mucositis
20%
Medicine and Dentistry
Low Drug Dose
100%
Conditioning
100%
Whole Body Radiation
100%
Allogeneic Stem Cell Transplantation
100%
Chronic Myelogenous Leukemia
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
40%
Cytokine
20%
Immunosuppressive Treatment
20%
Graft Versus Host Reaction
20%
Allograft
20%
Drug Megadose
20%
Kaplan Meier Method
20%
Cyclosporine
20%
Graft Failure
20%
Single Drug Dose
20%
Cyclophosphamide
20%
Engraftment
20%
Phase II Trials
20%
Acute Graft Versus Host Disease
20%
Organ Toxicity
20%
Oral Mucositis
20%
Nursing and Health Professions
Low Drug Dose
100%
Allogeneic Stem Cell Transplantation
100%
Whole Body Radiation
100%
Chronic Myeloid Leukemia
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
40%
Remission
20%
Confidence Interval
20%
Allograft
20%
Immunosuppressive Treatment
20%
Drug Megadose
20%
Ciclosporin
20%
Engraftment
20%
Kaplan Meier Method
20%
Graft Failure
20%
Single Drug Dose
20%
Cyclophosphamide
20%
Graft Versus Host Reaction
20%
Acute Graft Versus Host Disease
20%
Oral Mucositis
20%
Immunology and Microbiology
Low Drug Dose
100%
Myeloid
100%
Conditioning
100%
Allogeneic Stem Cell Transplantation
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
40%
Cytokine
20%
Graft-Versus-Host Disease
20%
Drug Megadose
20%
Immunosuppression
20%
Engraftment
20%
Acute Graft Versus Host Disease
20%
Ciclosporin
20%
Cyclophosphamide
20%
Allograft
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Cytokine
20%
Remission
20%
Acute Graft Versus Host Disease
20%
Graft Versus Host Reaction
20%
Phase II Trials
20%
Ciclosporin
20%
Cyclophosphamide
20%
Organ Toxicity
20%
Graft Failure
20%
Oral Mucositis
20%